An evidence-based scientific overview of Mazdutide (IBI362), evaluating its dual GLP-1 and glucagon receptor co-agonism across in-vitro, preclinical, and h
Semax is a synthetic ACTH(4-10) analog that exhibits potent neuroprotective, neurotrophic, and cognitive-modulating properties across clinical and pre-clin
Read more Semax Research Guide: Mechanisms, Neurotrophic Actions, and Clinical Evidence
Survodutide is a dual GLP-1 and glucagon receptor agonist demonstrating potent efficacy across clinical trials for obesity, metabolic dysfunction, and stea
A comprehensive scientific overview of Retatrutide (LY3437943), detailing its novel triple-receptor agonist mechanism across GLP-1, GIP, and GCGR, Phase 2
A comprehensive scientific evaluation of Eloralintide (LY3849891), an investigational long-acting amylin receptor agonist evaluated for weight management a
Read more Eloralintide Research Peptide: Mechanisms, Clinical Data, and Pharmacological Profile
A comprehensive scientific overview of Cagrilintide, a novel dual amylin and calcitonin receptor agonist (DACRA), detailing its pharmacokinetics, synergist
Read more Cagrilintide as a Research Peptide: Mechanism, Synergies, and Clinical Evidence
A structured Minto Pyramid review examining tirzepatide’s pharmacology, evidence hierarchy, and dual GIP/GLP-1 receptor agonism in metabolic and endocrine
A comprehensive scientific overview of semaglutide using the Minto Pyramid framework, examining its structural stability, receptor pharmacology, and eviden